Reports
Reports
The global cell separation technologies market size attained a value of USD 10.61 billion in 2022. The market is likely to rise further at a CAGR of 16.50% during the forecast period of 2023-2031, expected to attain a market value of USD 41.88 billion by 2031. The key factor contributing to the market growth include the rising prevalence of chronic and infectious diseases.
The methods of cell separation are used to isolate cells from groups of different cells. Cell separations are dependent on their physical properties, such as expression of form, volume, and protein. Techniques of cell separation play a vital role in chronic disease diagnoses, such as AIDS and cancer. It is also commonly used in work on stem cells and cancer.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Cell separation is the process of removing one cell group from another from within a biological specimen, such as blood or tissue. Examples include pathogenic bacteria isolated from food. The cell separation technologies industry can be divided based on segments like product, technology, application, and end-use.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry can be broadly categorised based on product into:
The industry can be divided on the basis of technology as:
The industry can be categorised based on application as:
The industry can be divided based on end-uses as:
The EMR report looks into the regional markets of cell separation technologies like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increasing prevalence of chronic diseases and expanded research activities focused on cell therapy are some of the major drivers of the global market for technologies for cell separation. However, increased government spending in the field of biotechnology and developments in separation technologies are also promoting the development of the global market in technologies for cell separation. Nevertheless, the lack of skilled healthcare professionals and regulatory issues hinders the development of the global cell separation technologies market. Improved stem cell demand in stem cell therapy is creating opportunities for innovation in the global cell separation market. The manufacturing companies' growing emphasis on clinical research is a key driver in the global market for cell separation technologies.
The report presents a detailed analysis of the following key players in the global cell separation technologies market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2016-2022 |
Forecast Period | 2023-2031 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Technology Type |
|
Breakup by Cell Type |
|
Breakup by Applications |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cell Separation Technology Market Overview
3.1 Global Cell Separation Technology Market Historical Value (2016-2022)
3.2 Global Cell Separation Technology Market Forecast Value (2023-2031)
4 Global Cell Separation Technology Market Landscape
4.1 Global Cell Separation Technology Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Cell Separation Technology Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
4.2.4 Analysis by End User
5 Global Cell Separation Technology Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis`
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Cell Separation Technology Market Segmentation
6.1 Global Cell Separation Technology Market by Product Type
6.1.1 Market Overview
6.1.2 Instruments
6.1.2.1 Centrifuges
6.1.2.2 Flow Cytometers
6.1.2.3 Filtration Systems
6.1.2.4 Magnetic-activated Cell Separator Systems
6.1.2.5 Others
6.1.3 Consumables
6.1.3.1 Reagents
6.1.3.2 Kits
6.1.3.3 Media
6.1.3.4 Sera
6.1.3.5 Beads
6.1.3.6 Disposables
6.1.3.7 Others
6.2 Global Cell Separation Technology Market by Technology Type
6.2.1 Market Overview
6.2.2 Immunomagnetic Cell Separation
6.2.3 Fluorescence-activated Cell Sorting
6.2.4 Density Gradient Centrifugation
6.2.5 Microfluidic Cell Separation
6.2.6 Others
6.3 Global Cell Separation Technology Market by Cell Type
6.3.1 Market Overview
6.3.2 Human Cells
6.3.3 Animals Cells
6.4 Global Cell Separation Technology Market by Applications
6.4.1 Market Overview
6.4.2 Stem Cell Research
6.4.3 Immunology
6.4.4 Neuroscience
6.4.5 Cancer Research
6.4.6 Other
6.5 Global Cell Separation Technology Market by End User
6.5.1 Market Overview
6.5.2 Biotechnology and Pharmaceutical Companies
6.5.3 Hospitals and Diagnostic Laboratories
6.5.4 Academic and Research Institutes
6.5.5 Others
6.6 Global Cell Separation Technology Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Cell Separation Technology Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Cell Separation Technology Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Cell Separation Technology Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Cell Separation Technology Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Cell Separation Technology Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Terumo Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 STEMCELL Technologies Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Miltenyi Biotec
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Merck KGaA,
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Akadeum Life Sciences
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Thermo Fisher Scientific Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 BD
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Bio-Rad Laboratories
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Carl Zeiss AG
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 General Electric
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 QIAGEN
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 IBA Lifesciences GmbH
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Elveflow
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 MPR Associates
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 PerkinElmer Inc.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Cell Separation Technology Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The global cell separation technologies market is projected to grow at a CAGR of 19% between 2023 and 2031.
The major drivers of the industry, such as the growing prevalence of chronic diseases, increasing population and rising health awareness, availability of improved diagnostic facilities, increased government investments in the medical sector, and growing technological advancements, are expected to aid the market growth.
The key market trends guiding the growth of the market include the growing clinical trials and advancements in the field of biotechnology.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Instruments and consumables are the major product segments of cell separation technologies in the industry.
The significant technologies available in the industry include gradient centrifugation, surface markers separation, and filtration based separation.
Oncology research, neuroscience research, stem cell research, microbiology, and immunology research, among others, are the major applications of the product in the market.
The major end use sectors of the product include hospitals and diagnostic laboratories, among others.
The major players in the industry are TERUMO BCT, INC., Miltenyi Biotec B.V. & Co. KG, Becton, Dickinson and Company (NYSE: BDX), and pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG, among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.